arrow
K

Konstantinos Stefanakis

Harvard Medical School
H指数:13
被引数:694

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Repurposing GLP-1 receptor agonists and SGLT-2 inhibitors in neurodegeneration and metabolically at-risk populations: Myth or reality? An overview of randomized clinical trials

GLP-1受体激动剂和SGLT-2抑制剂在神经退行性疾病及代谢高风险人群中的再利用:是神话还是现实?随机临床试验概述

2026-05-270
PRE
Effects of liraglutide treatment for 18 days on metabolic parameters, regional body composition and the myostatin-activin-follistatin-IGF-1 axis: Results from an exploratory, randomized, placebo-controlled, crossover study

利拉鲁肽治疗18天对代谢参数、区域性身体成分以及肌生长抑素-激活素-卵泡抑素-IGF-1轴的影响:一项探索性、随机、安慰剂对照、交叉研究的结果

2025-11-011
PRE
Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long interventional study
2023-05-298
OA